CoChat
Sign Up
Cited by 157Cervical Cancer and HPV ResearchWomen's cancer prevention and managementVaccine Coverage and Hesitancy

Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India

Open access
Rashid, Shazia, Labani, Satyanarayana, Das, Bhudev C.·2016·PLOS ONE
DOI 10.1371/journal.pone.0166713PMC PMC5115771
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Infection of specific high risk Human papillomaviruses (HPVs) is known to cause cervical cancer and two prophylactic vaccines have been developed against two major high risk HPV types 16 and 18 for prevention of cervical cancer. Because of societal, religious and ethical issues associated with the vaccination of adolescent girls in India together with lack of awareness about HPV and HPV vaccines, no successful HPV immunization program has been employed in India. OBJECTIVE: To determine knowledge, awareness and attitude of college students on HPV, HPV vaccine and cervical cancer. METHOD: A questionnaire-based survey was conducted in a total of 1580 undergraduate students between the age group 16-26 years comprising 684 girls and 876 boys. RESULTS: Out of a total of 1580 students, girls had more knowledge about cervical cancer (82.45%, p<0.001), HPV (45.61%, p<0.001) and HPV vaccines (44%, p<0.001) when compared to those in boys. However, knowledge about the types of HPV and vaccines was poor. Interestingly, students from biology-major had more knowledge and awareness about cervical cancer (81.89%, p<0.001) and HPV (46.58%, <0.001) when compared to non-biology students. Girls from both biology and non-biology group had higher awareness compared to boys. Analysis of odds ratio (ORs) along with 95% CI showed older girls with 1.2 to 3 fold (p<0.05) higher knowledge than boys. All students agreed that girls should get vaccinated against HPV (p<0.001). CONCLUSION: It is suggested that there is a need for educational intervention and awareness campaigns to augment HPV immunization program for control of cervical cancer in India.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0166713

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. [1]Duenas-Gonzalez A, Serrano-Olvera A, Cetina L, Coronel J. New molecular targets against cervical cancer. Int J Womens Health. 2014; 6: 1023– 31. 10.2147/IJWH.S49471 25525394 PMC4266260 · DOI
  2. [2]Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, et al Cancer mortality in India: A nationally representative survey. Lancet. 2012; 379: 1807– 1816. 10.1016/S0140-6736(12)60358-4 22460346 · DOI
  3. [4]Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila). 2012; 5: 18– 23. 10.1158/1940-6207.CAPR-11-0542 22219162 PMC3285475 · DOI
  4. [5]Das BC, Gopalkrishna V, Sharma JK, Roy M, Luthra UK. Human papillomavirus DNA in urine of women with preneoplastic and neoplastic cervical lesions. Lancet (London, England). 1992; 340: 1417– 8. Available: http://www.ncbi.nlm.nih.gov/pubmed/1360129 1360129
  5. [6]Pillai RM, Babu JM, Jissa VT, Lakshmi S, Chiplunkar S V, Patkar M, et al Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India. Int J Gynecol Cancer. 2010; 20: 1046– 51. 10.1111/IGC.0b013e3181e02fe0 20683415 · DOI · Paper page
  6. [7]Kerkar SC, Latta S, Salvi V, Mania-Pramanik J. Human Papillomavirus infection in asymptomatic population. Sex ReprodHealthc. 2011; 2: 7– 11. 10.1016/j.srhc.2010.11.001 21147453 · DOI
  7. [8]Das BC, Gopalkrishna V, Hedau S K S. Cancer of the Uterine Cervix and Human Papillomaviruses. Curr Sci. 2000; 78(1), 52– 63.
  8. [9]Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (London, England). 364: 1757– 65. 10.1016/S0140-6736(04)17398-4 15541448 · DOI
  9. [10]Villa LL, Costa RLR, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005; 6: 271– 8. 10.1016/S1470-2045(05)70101-7 15863374 · DOI
  10. [11]Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, et al Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56: 1– 24. Available: http://www.ncbi.nlm.nih.gov/pubmed/17380109 17380109
  11. [12]Choudhury P, John TJ. Human papilloma virus vaccines and current controversy. Indian Pediatr. 2010; 47: 724– 5. Available: http://www.ncbi.nlm.nih.gov/pubmed/20972294 20972294
  12. [13]Sharma K, Kathait A, Jain A, Kujur K, Raghuwanshi S, Bharti AC, et al Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-Sexual lifestyle. PLoS One. 2015; 10: 1– 13. 10.1371/journal.pone.0125693 25954813 PMC4425665 · DOI
  13. [14]Mehta S, Rajaram S, Goel G, Goel N. Awareness about Human Papilloma Virus and its Vaccine Among Medical Students. Indian J Community Med. 2013; 38: 92– 4. 10.4103/0970-0218.112438 23878421 PMC3714948 · DOI
  14. [15]Asthana S, Satyanarayana L. Cervical cancer screening from the perspective of a rural population of northern India. Ganga Ram J. 2013; 3: 128– 131.
  15. [17]Saha A, Nag Chaudhury A, Bhowmik P, Chatterjee R. Awareness of cervical cancer among female students of premier colleges in Kolkata, India. Asian Pacific J Cancer Prev. 2010; 11: 1085– 1090. 21133629
  16. [18]Bendik MK, Mayo RM, Parker VG. Knowledge, perceptions, and motivations related to HPV vaccination among college women. J Cancer Educ. 2011; 26: 459– 464. 10.1007/s13187-011-0200-8 21336980 · DOI
  17. [19]Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008; 99: 225– 9. 10.1038/sj.bjc.6604454 18628763 PMC2480983 · DOI
  18. [20]Lenselink CH, Schmeink CE, Melchers WJG, Massuger LFAG, Hendriks JCM, van Hamont D, et al Young adults and acceptance of the human papillomavirus vaccine. Public Health. 2008; 122: 1295– 301. 10.1016/j.puhe.2008.02.010 18619631 · DOI
  19. [21]Hussain S, Nasare V, Kumari M, Sharma S, Khan MA, Das BC, et al Perception of human papillomavirus infection, cervical cancer and HPV vaccination in North Indian population. PLoS One. 2014; 9: 1– 7. 10.1371/journal.pone.0112861 25386964 PMC4227878 · DOI
  20. [22]Das BC, Hussain S, Nasare V, Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine. 2008; 26: 2669– 79. 10.1016/j.vaccine.2008.03.056 18455843 · DOI
  21. [23]Prusty BK, Kumar A, Arora R, Batra S, Das BC. Human papillomavirus (HPV) DNA detection in self-collected urine. Int J Gynaecol Obstet. 2005; 90: 223– 7. 10.1016/j.ijgo.2005.06.004 16043176 · DOI
  22. [24]Pandey D, Vanya V, Bhagat S, VS B, Shetty J. Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PLoS One. 2012; 7: 8– 12. 10.1371/journal.pone.0040619 22859950 PMC3409219 · DOI
  23. [25]Ezem BU. Awareness and uptake of cervical cancer screening in Owerri, South-Eastern Nigeria. Ann Afr Med. 2007; 6: 94– 8. Available: http://www.ncbi.nlm.nih.gov/pubmed/18240495 18240495
  24. [26]Lambert EC. College students’ knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board FamPract. 14: 178– 83. Available: http://www.ncbi.nlm.nih.gov/pubmed/11355049 11355049
  25. [27]Pitts MK, Heywood W, Ryall R, Smith AM, Shelley JM, Richters J, et al Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women. Sex Health. 2010; 7: 299– 303. 10.1071/SH09150 20719218 · DOI
  26. [28]Blödt S, Holmberg C, Müller-Nordhorn J, Rieckmann N. Human Papillomavirus awareness, knowledge and vaccine acceptance: A survey among 18–25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health. 2012; 22: 808– 813. 10.1093/eurpub/ckr188 22199161 · DOI
  27. [29]Nnodu O, Erinosho L, Jamda M, Olaniyi O, Adelaiye R, Lawson L, et al Knowledge and attitudes towards cervical cancer and human papillomavirus: a Nigerian pilot study. Afr J Reprod Health. 2010; 14: 95– 108. Available: http://www.ncbi.nlm.nih.gov/pubmed/20695142 20695142
  28. [30]Sarah Reagan-Steiner,DavidYankey, Jenny Jeyarajah,Laurie D. Elam-Evans, James A. Singleton, C. Robinette Curtis, Jessica MacNeil, Lauri E. Markowitz SS. CDC report: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years—United States, 2014. 2015. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6429a3.htm PMC4584833 26225476
  29. [31]Simone B, Carrillo-Santisteve P, Lopalco P. Introduction of HPV vaccines in European Union countries—an update GUIDANCE Introduction of HPV vaccines in EU countries. 2012; 10.2900/60814 · DOI
  30. [32]Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, et al A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol. 1992; 36: 239– 45. Available: http://www.ncbi.nlm.nih.gov/pubmed/1315836 1315836
  31. [33]Patel KR, Vajaria BN, Begum R, Desai A, Patel JB, Shah FD, et al Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India. J Oral Pathol Med. 2014; 43: 293– 7. 10.1111/jop.12147 24372728 · DOI
  32. [34]Sureshkumar BT, Shanmughapriya S, Das BC, Natarajaseenivasan K. A population-based study of the prevalence of HPV in three districts of Tamil Nadu, India. Int J Gynaecol Obstet. 2015; 129: 58– 61. 10.1016/j.ijgo.2014.10.025 25556078 · DOI
  33. [35]Vinodhini K, Shanmughapriya S, Sanmugham S, Senthikumar G, Das BC, Natarajaseenivasan K. Prevalence of high-risk HPV and associated risk factors in cases of cervical carcinoma in Tamil Nadu, India. Int J Gynaecol Obstet. 2012; 119: 253– 6. 10.1016/j.ijgo.2012.06.019 22986098 · DOI
  34. [37]Bhatla N, Joseph E. Cervical cancer prevention & the role of human papillomavirus vaccines in India. Indian J Med Res. 2009; 130: 334– 40. Available: http://www.ncbi.nlm.nih.gov/pubmed/19901443 19901443
  35. [38]Lee PWH, Kwan TTC, Tam KF, Chan KKL, Young PMC, Lo SST, et al Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med (Baltim). 45: 130– 4. 10.1016/j.ypmed.2007.07.013 17707077 · DOI
  36. [39]Woodhall SC, Lehtinen M, Verho T, Huhtala H, Hokkanen M, Kosunen E. Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health. 2007; 40: 466– 9. 10.1016/j.jadohealth.2007.01.005 17448408 · DOI

Cited by

Sorted by citations

Authors
Rashid, S., Labani, S., & Das, B. C.
Affiliations
  • Amity University (IN)
  • Institute of Cytology and Preventive Oncology (IN)
Corresponding author
Das, Bhudev C.
ORCID
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2016-11-18
Volume
11
Issue
11
Pages
e0166713
ISSN
1932-6203 (ISSN-L)
DOI
10.1371/journal.pone.0166713
PMC
PMC5115771
OpenAlex
W2556177668
Cited by
157
References
2
Citations by year
2026: 13 · 2025: 27 · 2024: 20 · 2023: 20 · 2022: 23 · 2021: 14 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 3
FWCI
9.07
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords
human papillomavirus, HPV vaccine, cervical cancer, university students, adolescent girls, biology majors, gender differences, age differences, India
MeSH terms
Adolescent, Adult, Awareness, Uterine Cervical Neoplasms, Female, Humans, India, Health Knowledge, Attitudes, Practice, Male, Surveys and Questionnaires, Risk Factors, Students, Odds Ratio, Papillomavirus Infections, Papillomavirus Vaccines, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review